Treatment: New breast cancer hope
- New England Cancer Connect
- Jul 27, 2017
- 1 min read
A combination therapy halting cancer growth for twice as long in women with the most common type of advanced breast cancer, is being tested for early stage cancer in a bid to save more lives. A new class of drug that works to stop cancer, called CDK4 and CDK6 inhibitors, has consistently shown it can double the effect of common anti-hormone treatments, delaying tumour growth from 10 months to 20 months. The Herald Sun, 28 July 2017, page 25; The Hobart Mercury, 28 July 2017, page 9; The Adelaide Advertiser, 28 July 2017, page 1; The Courier Mail, 28 July 2017, page 7

Comments